arrow
E

Etan Orgel

children's hospital los angeles
H指数:29
被引数:2,980

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ethnic Differences in the Association Between SOD2 rs4880 and Hepatotoxicity in Pediatric Acute Lymphoblastic Leukemia: A Report From the REDIAL Consortium

不同种族中SOD2 rs4880与儿童急性淋巴细胞白血病肝毒性关联的差异:REDIAL联盟的报告

2026-07-010
OAAI
Factors associated with unplanned healthcare encounters in pediatric cancer patients

影响儿科癌症患者非计划医疗就诊的相关因素

2026-05-210
PRE
Toxicity from asparaginase during acute lymphoblastic leukemia induction: A report from the Children’s Oncology Group

急性淋巴细胞白血病诱导期间天冬酰胺酶的毒性:儿童肿瘤学组的报告

2026-05-070
OAAI
Utility of a Second Interim Maintenance Phase to Improve Outcomes for Pediatric Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group

在儿童急性淋巴细胞白血病中增加第二期中期巩固治疗以提高疗效:儿童肿瘤学组报告

BLOOD
IF23.1
2024-11-050
PRE
Trial in Progress: Update on the TACL T2020-003 Randomized Phase 2 Trial to Improve Diet and Exercise in Acute Leukemia (IDEAL-2)

试验进行中:TACL T2020-003随机II期试验进展更新,旨在改善急性白血病患者的饮食和运动(IDEAL-2)

BLOOD
IF23.1
2024-11-050
PRE
An Exome Capture-Based RNA-Sequencing Assay for Genome-Wide Identification and Prioritization of Clinically Important Fusions in Pediatric Tumors
2024-02-012
OAAI
Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX- ALL): a phase 3, open-label, randomised, controlled trial

阿哌沙班与非抗凝药物预防新诊断急性淋巴细胞白血病或淋巴瘤患儿静脉血栓栓塞的比较 (prevapix-all): 一项3期、开放标签、随机、对照试验

2024-01-0112
PRE